Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Multiple Sclerosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Multiple Sclerosis
    TopAbstracts in Multiple Sclerosis 05/15/2008 - (DGNews)
    Fluoxetine May Help to Curb Disease Activity in Multiple Sclerosis - (DGNews)
    TopAbstracts in Multiple Sclerosis 05/01/2008 - (DGNews)
    Interferon Beta-1a Therapy Improves Quality of Life in Multiple Sclerosis: Presented at AAN - (DGDispatch)
    TopAbstracts in Multiple Sclerosis 04/17/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Multiple Sclerosis
    • Step-Wise Use of Immunomodulatory/Immunosuppressive Agents Provides Options in MS
    • Available Data on the Safety of Monoclonal Antibodies in MS
    • Oral Therapies May Expand Therapeutic Options in MS
    • Clinical Concepts in Multiple Sclerosis: Emerging Trends in Imaging, Immunology, and Therapeutics
      Mastering Multiple Sclerosis: Challenges and Opportunities For Managed Care Pharmacists

      Webcasts/CME archive

       Recent cases - Multiple Sclerosis
        Central Auditory Evaluation in Multiple Sclerosis: Case Report
        Recurrent Acute Hepatitis in Patient Receiving Pulsed Methylprednisolone for Multiple Sclerosis
        Multiple Sclerosis in Childhood: Presenting as Bilateral Optic Neuritis
        Femoral and Sciatic Nerves Block (Biblock) in Orthopedic Traumatologic Lower Limbs Surgery in Patients with Multiple Sclerosis
        Acute Myeloid Leukaemia Induced by Mitoxantrone: Case Report

        Cases archive
          




        my personal edition > multiple sclerosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Risk of Multiple Sclerosis Exacerbation Doubles Following a Stressful Event

        BMJ

        09/19/2003
        By Joene Hendry


        The risk of increased disease exacerbation is doubled in patients with multiple sclerosis after they experience a non-disease related stressful event, according to the findings of a prospective study of adults with relapsing-remitting multiple sclerosis.

        "The knowledge that stressful events are associated with disease activity adds important information to the limited insight that patients and their caregivers have on this unpredictable disease," writes R. Q. Hintzen, MD, of Erasmus MC, Rotterdam, the Netherlands and colleagues. They analysed the relationship between self reported stressful events and disease exacerbation and infections in 73 patients, aged 18 to 55 years, with relapsing-remitting multiple sclerosis. The patients were mobile (at most required a cane for walking) and had a score of 0 to 6.0 on the expanded disability status scale. The cohort reported at least 2 exacerbations within 24 months prior to inclusion in the study but had no other serious conditions. The cohort's mental health scores were comparable with a group of individuals with relapsing-remitting multiple sclerosis who were not study participants.

        The investigators defined an exacerbation as a worsening of existing symptoms or the appearance of new symptoms lasting more than 24 hours after a minimum of 30 days of improvement or stability. Over an average follow up of 1.4 years, 70 of the 73 participants reported at least one stressful event, as tallied in weekly diaries, for an overall total of 457 events.

        A total of 134 disease exacerbations occurred in 56 patients and a total of 136 episodes of infections occurred in 57 patients, for an average of 1.3 exacerbations or 1.3 infections per year. A Cox univariate regression analysis revealed that the risk of exacerbation was 2.2 times higher during the 4-week period after a stressful event. The risk for a second exacerbation was increased 2.7 times after a 4-week period in which a stressful event occurred.

        Analysis of the increased risk of exacerbations related to infections shows a relative risk of 2.9 for the first exacerbation, 2.7 for the second, and 3.2 for a third exacerbation related to infection. The period of high risk related to infection begins 2 weeks prior to the onset of infection and continues until 5 weeks post infection.

        The investigators note that in this study the patients were regularly evaluated at close intervals, additional evaluations were arranged in cases of infection or exacerbation, and all relapses were confirmed by a physician. Their findings indicate that stress and infection were independently associated with an increased risk of disease exacerbation.

        BMJ 2003;327:646-9.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send